Reference
L and D amino acids
Nineteen of the twenty amino acids come in two mirror-image forms. Life uses almost exclusively one of them, drug designers deliberately use the other, and the standard analytical methods cannot tell them apart.
What chirality is
A molecule is chiral when it cannot be superimposed on its own mirror image — the way a left hand cannot be laid onto a right hand palm-down and match. The two versions contain the same atoms joined in the same order, and are still different objects.
Amino acids are chiral because the central carbon carries four different groups. Arrange those four in space and there are two ways to do it. The two forms are labelled L and D.
Glycine is the exception. Its side chain is a single hydrogen, which leaves the central carbon holding two identical groups — so there is only one version of it, and no L or D to distinguish.
Why life picked one
Proteins in living things are built almost entirely from L-amino acids. The reason it matters is that enzymes are themselves chiral: an enzyme that acts on a peptide has a binding site shaped for one handedness, and the mirror image simply does not fit.
That has a direct consequence for anything synthetic. The machinery that breaks peptides down is built for L-residues, and a chain containing D-residues is not recognised properly by it.
Why designers use the other one
That non-recognition is useful, and it is deliberately exploited. Substituting a D-amino acid at a position where an enzyme would normally cut produces a chain that survives longer, without otherwise changing the molecule much.
The most thorough version of the trick is the retro-inverso design: reverse the sequence and swap every residue for its D form. The reversal and the mirroring cancel out in terms of shape, so the side chains end up arranged roughly as they were — but the backbone is built from residues nothing is equipped to cut. FOXO4-DRI is exactly this, and the DRI in the name stands for D-retro-inverso.
In a written sequence a D-residue is marked with a D- prefix. An unmarked residue
is L by convention, which means the absence of a marker is itself information —
see how sequences are written.
Racemisation: the form that changes on its own
Handedness is not permanently fixed. Under some conditions an L-residue can flip to D on its own, a process called racemisation. It is slow, and it is accelerated by heat, by extremes of pH, and by time in solution.
This makes it a genuine degradation route rather than a curiosity. A peptide that has partly racemised has not lost any atoms — it weighs the same and looks the same to most measurements — but some fraction of it is now a different molecule. It is one more reason material is kept dry, cold and sealed.
The blind spot
Here is the awkward part. The two standard analytical methods on a peptide certificate are largely blind to this:
- Mass spectrometry cannot see it at all. Mirror images contain identical atoms and have identical masses. An entirely D-form peptide and its L-form counterpart are the same number.
- Ordinary HPLC sees it only sometimes. A single flipped residue in a longer chain produces a molecule that may or may not separate from the original, depending on the sequence and the method.
Establishing stereochemistry properly needs methods chosen for it, and those are not part of a routine purity and identity report. It is not a reason to distrust such a report — it is a reason to know what it covers, which is the point of reading a certificate field by field.
